MARLBOROUGH, Mass., July 1, 2016 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2016 on Thursday, July 28, 2016 at 8:00 a.m. ET.

The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer.

A live webcast of the conference call will be available on the Investor Relations section of the website at investors.bostonscientific.com. We encourage interested parties to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be accessible at investors.bostonscientific.com approximately one hour following the completion of the conference call and available for approximately one year.

The company will issue a news release announcing financial results for the second quarter on Thursday, July 28, 2016, prior to the conference call.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.



    CONTACTS

    Media:                        Investors:

    Tom Keppeler                  Susie Lisa, CFA

    508-683-6585 (office)         508- 683-5565 (office)

    Media Relations               Investor Relations

    Boston Scientific Corporation Boston Scientific Corporation

    thomas.keppeler@bsci.com      investor_relations@bsci.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-webcast-conference-call-discussing-second-quarter-2016-financial-results-on-july-28-300292307.html

SOURCE Boston Scientific Corporation